| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo
|
Wang, Shudan
|
|
2018
|
83 |
3 |
p. 519-530
|
artikel
|
| 2 |
A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
|
Melosky, Barbara L.
|
|
2018
|
83 |
3 |
p. 411-417
|
artikel
|
| 3 |
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
|
Cristea, Mihaela C.
|
|
2019
|
83 |
3 |
p. 589-598
|
artikel
|
| 4 |
A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas
|
Liu, Xuyan
|
|
2018
|
83 |
3 |
p. 443-449
|
artikel
|
| 5 |
A successful compartmental approach for the treatment of breast cancer brain metastases
|
Nguyen, Thuy T.
|
|
2019
|
83 |
3 |
p. 573-580
|
artikel
|
| 6 |
A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer
|
Duska, Linda R.
|
|
2018
|
83 |
3 |
p. 473-482
|
artikel
|
| 7 |
Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms
|
Gusella, Milena
|
|
2018
|
83 |
3 |
p. 493-500
|
artikel
|
| 8 |
Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study
|
Ferrandina, Gabriella
|
|
2018
|
83 |
3 |
p. 431-438
|
artikel
|
| 9 |
Evaluation of the effects of an oral notch inhibitor, crenigacestat (LY3039478), on QT interval, and bioavailability studies conducted in healthy subjects
|
Yuen, Eunice
|
|
2018
|
83 |
3 |
p. 483-492
|
artikel
|
| 10 |
Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study
|
Shaik, Naveed
|
|
2018
|
83 |
3 |
p. 463-472
|
artikel
|
| 11 |
Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?
|
Abu-Amna, Mahmoud
|
|
2018
|
83 |
3 |
p. 545-550
|
artikel
|
| 12 |
Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: data from the FDA adverse event reporting system
|
Zhou, Huaqiang
|
|
2019
|
83 |
3 |
p. 599-601
|
artikel
|
| 13 |
Low dosage of apatinib monotherapy as rescue treatment in advanced lung squamous cell carcinoma
|
Zeng, Da-xiong
|
|
2018
|
83 |
3 |
p. 439-442
|
artikel
|
| 14 |
Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
|
Sasaki, Ken
|
|
2019
|
83 |
3 |
p. 581-587
|
artikel
|
| 15 |
Pharmacokinetics and bioequivalence of generic and branded abiraterone acetate tablet: a single-dose, open-label, and replicate designed study in healthy Chinese male volunteers
|
Wang, Chunhua
|
|
|
83 |
3 |
p. 509-517
|
artikel
|
| 16 |
Pharmacokinetics and bioequivalence of generic and branded abiraterone acetate tablet: a single-dose, open-label, and replicate designed study in healthy Chinese male volunteers
|
Wang, Chunhua
|
|
2018
|
83 |
3 |
p. 509-517
|
artikel
|
| 17 |
Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
|
Paluri, Ravi
|
|
2019
|
83 |
3 |
p. 551-559
|
artikel
|
| 18 |
Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome
|
Iihara, Hirotoshi
|
|
2018
|
83 |
3 |
p. 393-398
|
artikel
|
| 19 |
Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205)
|
Suwa, Yusuke
|
|
2018
|
83 |
3 |
p. 419-424
|
artikel
|
| 20 |
Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer
|
Oh, Sung Yong
|
|
2018
|
83 |
3 |
p. 501-508
|
artikel
|
| 21 |
Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells
|
Quan, Yu Hua
|
|
2018
|
83 |
3 |
p. 399-410
|
artikel
|
| 22 |
Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report
|
Siebert, Matthieu
|
|
2018
|
83 |
3 |
p. 425-430
|
artikel
|
| 23 |
Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells
|
Aggarwal, Sadhna
|
|
2018
|
83 |
3 |
p. 451-461
|
artikel
|
| 24 |
Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model
|
Secombe, Kate R.
|
|
2018
|
83 |
3 |
p. 531-543
|
artikel
|
| 25 |
The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis
|
He, Liyun
|
|
2019
|
83 |
3 |
p. 561-571
|
artikel
|
Tijdschrift beschrijving